James Hardie Industries JHX
$26.48 −$0.29 (-1.08%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $26.48 0.00%
Open$26.68
Prev close$26.77
Day range$26.37 – $27.47
Volume8.16M
Market cap$15.40B
P/E (TTM)42.7
Dividend yield–
Fundamentals
Latest reported quarter: Q2, ended Sep 2026
Revenue$1.43B+23.7% YoY
Operating profit$279.30M+97.2% YoY
Net profit$151.00M+370.6% YoY
Diluted EPS$0.26+360.0% YoY
Free cash flow$281.20M+682.2% YoY
Operating cash flow$349.70M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin37.4%
Operating margin16.3%
Net margin6.2%
Return on equity5.4%
Return on assets2.6%
Return on invested capital4.5%
Current ratio2.11
Liabilities / assets49.8%
Cash & investments$323.10M
Total debt$4.21B
Net cash (debt)-$3.89B
Free cash flow / sales12.0%
Where the revenue comes from
Quarter 2027/Q2
By business line
Income statement
| Line item | 2027 Q2 | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $1.43B | $1.47B | $4.84B | $1.40B | $1.24B |
| Total Operating Revenue | $1.43B | $1.47B | $4.84B | $1.40B | $1.24B |
| Cost of Revenue | $865.80M | $925.90M | $3.11B | $880.50M | $791.60M |
| Gross Profit | $562.40M | $548.70M | $1.73B | $523.40M | $448.20M |
| Operating Expense | $283.10M | $310.80M | $1.01B | $306.00M | $266.30M |
| Selling and Admin Expenses | $268.50M | $295.40M | $946.40M | $289.80M | $249.70M |
| Research & Development | $14.60M | $15.40M | $60.70M | $16.20M | $16.60M |
| Operating Profit | $279.30M | $237.90M | $722.50M | $217.40M | $181.90M |
| Net Non-Operating Interest Income (Expense) | -$54.80M | -$61.50M | -$231.10M | -$62.30M | -$65.60M |
| Non-Operating Interest Expense | $54.80M | $61.50M | $231.10M | $62.30M | $65.60M |
| Other Income (Expense) | $2.90M | -$19.10M | -$284.70M | -$108.70M | -$5.70M |
| Special Income (Charges) | -$16.00M | -$20.20M | -$274.90M | -$108.60M | -$5.70M |
| -Less:Restructuring and Mergern & Acquisition | $15.70M | $21.80M | $223.10M | $58.00M | $5.40M |
| -Less:Other Special Charges | $300,000.00 | -$1.60M | $51.80M | $50.60M | $300,000.00 |
| Other Non-Operating Income (Expenses) | $18.90M | $1.10M | -$9.80M | -$100,000.00 | – |
| Pretax Profit | $227.40M | $157.30M | $206.70M | $46.40M | $110.60M |
| Tax | $77.60M | $53.00M | $102.70M | $17.90M | $41.90M |
| Net Profit | $151.00M | $104.30M | $104.00M | $28.50M | $68.70M |
| Profit from Continuing Operations | $149.80M | $104.30M | $104.00M | $28.50M | $68.70M |
| Net Income from Discontinuous Operations | $1.20M | – | – | – | – |
| Net Income to Parent Company | $151.00M | $104.30M | $104.00M | $28.50M | $68.70M |
| Net Income to Common Stockholders | $151.00M | $104.30M | $104.00M | $28.50M | $68.70M |
| Basic EPS | $0.26 | $0.18 | $0.19 | $0.05 | $0.12 |
| Diluted EPS | $0.26 | $0.18 | $0.19 | $0.05 | $0.12 |
Balance sheet
| Line item | 2027 Q2 | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 |
|---|---|---|---|---|---|
| Total Assets | $13.40B | $13.49B | $13.69B | $13.69B | $13.80B |
| Total Current Assets | $2.54B | $1.76B | $1.83B | $1.83B | $1.72B |
| Cash and Cash Equivalents & Short-Term Investments | $323.10M | $289.90M | $269.20M | $269.20M | $344.20M |
| -Cash and Cash Equivalents | $323.10M | $289.90M | $269.20M | $269.20M | $344.20M |
| Receivables | $430.90M | $499.60M | $520.80M | $520.80M | $316.80M |
| -Accounts Receivable | $430.90M | $499.60M | $441.00M | $441.00M | $311.00M |
| Inventory | $511.70M | $612.10M | $635.70M | $635.70M | $665.80M |
| Restricted Cash | $243.60M | $245.00M | $273.70M | $273.70M | $218.00M |
| Other Current Assets | $94.70M | $101.80M | $116.50M | $116.50M | $162.70M |
| Total Non-Current Assets | $10.86B | $11.73B | $11.86B | $11.86B | $12.09B |
| Net PPE | $2.83B | $3.28B | $3.32B | $3.32B | $3.33B |
| -Gross PPE | $4.62B | $5.16B | $5.11B | $5.11B | $5.04B |
| -Accumulated Depreciation | -$1.79B | -$1.88B | -$1.79B | -$1.79B | -$1.71B |
| Goodwill and Other Intangible Assets | $7.62B | $8.04B | $8.12B | $8.12B | $8.35B |
| -Goodwill | $4.57B | $4.78B | $4.78B | $4.78B | $4.82B |
| -Other Intangible Assets | $3.04B | $3.26B | $3.34B | $3.34B | $3.53B |
| Non-Current Deferred Assets | $332.50M | $347.60M | $355.80M | $355.80M | $346.80M |
| Other Non-Current Assets | $78.40M | $70.90M | $27.20M | $27.20M | $22.20M |
| Total Liabilities | $6.67B | $6.95B | $7.26B | $7.26B | $7.41B |
| Total Current Liabilities | $1.20B | $1.11B | $1.16B | $1.16B | $1.11B |
| Payables | $577.20M | $726.10M | $464.70M | $464.70M | $681.60M |
| -Accounts Payable | $561.40M | $699.60M | $351.40M | $351.40M | $667.20M |
| -Total Tax Payable | $15.80M | $26.50M | $13.10M | $13.10M | $14.40M |
| Current Accrued Expenses | $148.80M | $135.80M | $439.50M | $439.50M | $161.90M |
| Short-Term Debt and Capital Lease Obligation | $91.30M | $83.70M | $82.30M | $82.30M | $80.80M |
| -Current Debt | $54.70M | $43.80M | $43.80M | $43.80M | $43.80M |
| -Current Capital Lease Obligation | $36.60M | $39.90M | $38.50M | $38.50M | $37.00M |
| Other Current Liabilities | $385.40M | $163.90M | $168.00M | $168.00M | $187.00M |
| Total Non-Current Liabilities | $5.47B | $5.84B | $6.11B | $6.11B | $6.29B |
| Non-Current Accrued Expenses | $54.40M | $53.90M | $53.30M | $53.30M | $42.50M |
| Long Term Debt and Capital Lease Obligation | $4.16B | $4.44B | $4.70B | $4.70B | $4.78B |
| -Long Term Debt | $3.96B | $4.23B | $4.49B | $4.49B | $4.57B |
| -Long Term Capital Lease Obligation | $194.10M | $205.40M | $212.20M | $212.20M | $216.10M |
| Non-Current Deferred Liabilities | $376.40M | $426.30M | $399.70M | $399.70M | $564.60M |
| Other Non-Current Liabilities | $884.00M | $924.80M | $930.60M | $930.60M | $888.20M |
| Total Equity | $6.73B | $6.54B | $6.43B | $6.43B | $6.40B |
| Stockholders' Equity | $6.73B | $6.54B | $6.43B | $6.43B | $6.40B |
| Capital Stock | $327.70M | $326.80M | $326.70M | $326.70M | $326.40M |
| -Common Stock | $327.70M | $326.80M | $326.70M | $326.70M | $326.40M |
| Additional Paid-In Capital | $4.36B | $4.33B | $4.32B | $4.32B | $4.31B |
| Retained Earnings | $2.09B | $1.93B | $1.83B | $1.83B | $1.80B |
| Gains/Losses Not Affecting Retained Earnings | -$45.30M | -$49.60M | -$46.30M | -$46.30M | -$39.20M |
| -Taxes Receivable | – | – | $37.70M | $37.70M | – |
| -Other Receivables | – | – | $42.10M | $42.10M | $5.80M |
| Non Current Accounts Receivables | – | – | $20.80M | $20.80M | $21.50M |
| Defined Pension Benefit | – | – | $18.70M | $18.70M | $17.50M |
| -Other Payable | – | – | $100.20M | $100.20M | – |
| Employee Benefits | – | – | $18.70M | $18.70M | $17.50M |
Cash flow
| Line item | 2027 Q2 | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 |
|---|---|---|---|---|---|
| Operating Cash Flow | $349.70M | $344.00M | $589.80M | $134.40M | $201.10M |
| Net cash flow from continuing operations | $349.70M | $344.00M | $589.80M | $134.40M | $201.10M |
| Net Income from Continuing Operations | $151.00M | $104.30M | $104.00M | $28.50M | $68.70M |
| Depreciation & Depletion & Amortization | $162.60M | $168.80M | $493.50M | $163.00M | $147.60M |
| Deferred Tax | $2.80M | $29.00M | -$17.90M | -$23.50M | -$2.10M |
| Other Non-Cash Items | -$21.20M | -$10.30M | $108.30M | $74.00M | -$4.90M |
| Change in Working Capital | $36.20M | $40.20M | -$109.90M | -$116.40M | $8.70M |
| -Change in Receivables | -$13.30M | $56.80M | -$11.80M | -$165.60M | $50.70M |
| -Change in Inventory | $28.10M | $26.00M | -$48.50M | $28.90M | -$27.20M |
| -Change in Prepaid Assets | $18.80M | -$20.60M | -$1.20M | -$2.80M | $16.50M |
| -Change in Payables and Accrued Expense | $16.70M | -$7.70M | -$1.10M | $36.00M | -$17.80M |
| -Change In Other Working Capital | -$14.10M | -$14.30M | -$47.30M | -$12.90M | -$13.50M |
| Net cash flow from investing | -$68.50M | -$103.60M | -$4.21B | -$88.00M | $300,000.00 |
| Net Cash Flow from Continuing Investing Activities | -$68.50M | -$103.60M | -$4.21B | -$88.00M | $300,000.00 |
| Capital Expenditure | $0.00 | $0.00 | -$6.10M | $0.00 | -$1.00M |
| Net PPE Purchase and Sale | -$68.50M | -$89.80M | -$275.70M | -$81.10M | $1.30M |
| Net Other Investing Changes | $0.00 | -$13.80M | -$6.90M | – | – |
| Financing Cash Flow | -$251.90M | -$261.40M | $3.35B | -$85.30M | -$412.40M |
| Net Cash Flow from Continuing Financing Activities | -$251.90M | -$261.40M | $3.35B | -$85.30M | -$412.40M |
| Net Issuance Payments Of Debt | -$262.60M | -$262.30M | $3.41B | -$82.90M | -$407.40M |
| Proceeds from Stock Option Exercised | $12.50M | $1.00M | $1.70M | – | – |
| Net Other Financing Charges | -$1.80M | -$100,000.00 | -$43.70M | $9.60M | -$5.00M |
| Ending Cash Balance | $352.60M | $322.00M | $344.40M | $344.40M | $374.90M |
| Net Change in Cash | $29.30M | -$21.00M | -$267.80M | -$38.90M | -$211.00M |
| Beginning Cash Balance | $322.00M | $344.40M | $605.60M | $374.90M | $587.00M |
| Effect of Exchange Rate Changes | $1.30M | -$1.40M | $6.60M | $8.40M | -$1.10M |
| Free Cash Flow | $281.20M | $254.20M | $199.80M | $53.30M | $93.20M |
| Gain/Loss from Continuing Operations | – | – | -$26.20M | $0.00 | – |
| Net Business Purchase and Sale | – | – | -$3.92B | $0.00 | $0.00 |
| Net Common Stock Issuance | – | – | -$13.70M | -$13.70M | $0.00 |
No comments yet — be the first to weigh in on JHX.
Sign in to join the discussion.